BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21162801)

  • 1. [Influence and distribution of CD133 and CD34 antigen expression in proximal tubule epithelial cells during ischemia/reperfusion injury in rats].
    Chen FM; Jiang XN; Shi JQ; Yan B; Ren DS; Gu J; Li DB; Zhang Y; Shen J; Liang J; Wang Y
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2864-8. PubMed ID: 21162801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis.
    Kim K; Park BH; Ihm H; Kim KM; Jeong J; Chang JW; Cho YM
    Histol Histopathol; 2011 Feb; 26(2):223-32. PubMed ID: 21154236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.
    Chen Y; Lu B; Wang J; Chen S; Lin Z; Ma X; Liu Y; Zhao B; Chen Y
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):319-26. PubMed ID: 25444027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
    Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
    Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.
    Bartling B; Koch A; Simm A; Scheubel R; Silber RE; Santos AN
    Int J Mol Med; 2010 Jan; 25(1):89-96. PubMed ID: 19956906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased number of circulating progenitor cells after implantation of ventricular assist devices.
    Manginas A; Tsiavou A; Sfyrakis P; Giamouzis G; Tsourelis L; Leontiadis E; Degiannis D; Cokkinos DV; Alivizatos PA
    J Heart Lung Transplant; 2009 Jul; 28(7):710-7. PubMed ID: 19560700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cord blood-derived neurons are originated from CD133+/CD34 stem/progenitor cells in a cell-to-cell contact dependent manner.
    Zangiacomi V; Balon N; Maddens S; Lapierre V; Tiberghien P; Schlichter R; Versaux-Botteri C; Deschaseaux F
    Stem Cells Dev; 2008 Oct; 17(5):1005-16. PubMed ID: 18811243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection and analysis of CD271, CD133 and CD34 expressions in bone marrow cells by flow cytometry with three color fluorescence labelling].
    Zhou J; Zhu B; DU HY; Sun TS; Zhang CH; Yang LG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):133-6. PubMed ID: 19236764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
    Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
    Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
    Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
    Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells.
    Bissels U; Wild S; Tomiuk S; Hafner M; Scheel H; Mihailovic A; Choi YH; Tuschl T; Bosio A
    Stem Cells; 2011 May; 29(5):847-57. PubMed ID: 21394831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between the distribution of CD133-positive cells and the proliferation of microvessels in glioblastoma multiforme].
    Wang HM; Yang XJ; Dong XT; Li Y; Wang W; Ming HL; Zhang B; Yu SP
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(11):781-5. PubMed ID: 21600108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic angiogenesis by transplantation of human embryonic stem cell-derived CD133+ endothelial progenitor cells for cardiac repair.
    Rufaihah AJ; Haider HK; Heng BC; Ye L; Tan RS; Toh WS; Tian XF; Sim EK; Cao T
    Regen Med; 2010 Mar; 5(2):231-44. PubMed ID: 20210583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of CD133 in the bone marrow of patients with myelodysplastic syndrome and its clinical significance].
    Zhong LY; DU X; Geng SX; Weng JY; Zheng HT; Wu SJ; Li YQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):854-5. PubMed ID: 21602141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion.
    Persy VP; Verstrepen WA; Ysebaert DK; De Greef KE; De Broe ME
    Kidney Int; 1999 Aug; 56(2):601-11. PubMed ID: 10432399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?
    Senegaglia AC; Barboza LA; Dallagiovanna B; Aita CA; Hansen P; Rebelatto CL; Aguiar AM; Miyague NI; Shigunov P; Barchiki F; Correa A; Olandoski M; Krieger MA; Brofman PR
    Exp Biol Med (Maywood); 2010 Jan; 235(1):119-29. PubMed ID: 20404026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using CD133 positive U251 glioblastoma stem cells to establish nude mice model of transplanted tumor.
    Jin F; Gao C; Zhao L; Zhang H; Wang HT; Shao T; Zhang SL; Wei YJ; Jiang XB; Zhou YP; Zhao HY
    Brain Res; 2011 Jan; 1368():82-90. PubMed ID: 20971095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mobilization effects of SCF along with G-CSF on bone marrow stem cells and endothelial progenitor cells in rats with unilateral ureteral obstruction].
    Zhang JJ; Yi ZW; Dang XQ; He XJ; Wu XC
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Apr; 9(2):144-8. PubMed ID: 17448311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients.
    Feller N; van der Pol MA; Waaijman T; Weijers GW; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Clin Cancer Res; 2005 Jul; 11(13):4793-801. PubMed ID: 16000576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    Hicks C; Wong R; Manoharan A; Kwan YL
    Ann Hematol; 2007 Aug; 86(8):591-8. PubMed ID: 17492259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.